A new measure of firm-level AI investments is proposed, using a unique combination of worker resume and job postings datasets, which reveals a stark increase in AI investments across sectors.
The Central Europe, Eastern Europe, and Central Asia region face the highest levels of CVD mortality globally, and the Sub-Saharan Africa region had the highest proportion of countries scoring two or less for the WHF Policy Index.
The empirical results show that the technology context (IT infrastructure and digital tools) along with the existing level of innovation are the main drivers that act as stepping stones in digital technology adoption.
This paper introduces a new class of cooperative games that arise from production-inventory problems, where several agents have to cover their demand over a finite time horizon and shortages are allowed.
This study applies advanced machine learning techniques such as deep learning, regression models, and ensemble learning to improve forecasting accuracy aimed at achieving efficient resource allocation and investigates fault prediction in New Energy Vehicles and its implications for grid stability and energy demand management.
It is shown that a rising Bitcoin price is followed by entry of new users, in particular among more risk-seeking segments of the population, and that when prices rise larger holders sell, likely making a return at retail users’ expense.
The economic burden of cardiovascular risk factors and overt cardiovascular disease in the United States is projected to increase substantially in the coming decades and development and deployment of cost-effective programs and policies to promote cardiovascular health are urgently needed to rein in costs and to equitably enhance population health.
This study enhances the existing discourse on DT and green innovation by furnishing empirical substantiation for the non-linear influence exerted by DT on green innovation, and imparts insights into the mechanisms and contextual limitations governing this association.
The mean cost of developing a new drug from 2000 to 2018 was $172.7 million but increased to $515.8 million when cost of failures was included and to $879.3 million when both drug development failure and capital costs were included.
Article Galaxy Pages is a free service from Research Solutions, a company that offers access to content in collaboration with publishing partners, online repositories and discovery services.